{"cik":2029039,"taxonomy":"us-gaap","tag":"EarningsPerShareBasic","label":"Earnings Per Share, Basic","description":"The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.","entityName":"NASUS PHARMA LTD.","units":{"USD/shares":[{"start":"2023-01-01","end":"2023-12-31","val":-0.15,"accn":"0001493152-26-012559","fy":2025,"fp":"FY","form":"20-F","filed":"2026-03-25","frame":"CY2023"},{"start":"2024-01-01","end":"2024-06-30","val":-0.13,"accn":"0001493152-25-029210","fy":2025,"fp":"Q2","form":"6-K","filed":"2025-12-29"},{"start":"2024-01-01","end":"2024-12-31","val":-0.22,"accn":"0001493152-26-012559","fy":2025,"fp":"FY","form":"20-F","filed":"2026-03-25","frame":"CY2024"},{"start":"2025-01-01","end":"2025-06-30","val":-0.17,"accn":"0001493152-25-029210","fy":2025,"fp":"Q2","form":"6-K","filed":"2025-12-29"},{"start":"2025-01-01","end":"2025-12-31","val":-0.72,"accn":"0001493152-26-012559","fy":2025,"fp":"FY","form":"20-F","filed":"2026-03-25","frame":"CY2025"}]}}